Testing effectiveness (Phase 2)Study completedNCT00001866What this trial is testingEye Muscle Surgery to Treat Congenital NystagmusWho this might be right forNystagmus National Eye Institute (NEI) 15
Not applicableLooking for participantsNCT04770519What this trial is testingGenetic Studies of Strabismus, Nystagmus, and Associated DisordersWho this might be right forStrabismusNystagmus, Congenital Boston Children's Hospital 400
Not applicableApproved For MarketingNCT02189720What this trial is testingExpanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic SyndromeWho this might be right forCongenital Myasthenic SyndromeLambert-Eaton Myasthenic SyndromeNystagmus, Acquired Catalyst Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00661440What this trial is testingEfficacy and Safety Study of Neramexane to Treat Congenital and Acquired NystagmusWho this might be right forNystagmus, Congenital IdiopathicNystagmus, Acquired Merz Pharmaceuticals GmbH 48
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Testing effectiveness (Phase 2)Ended earlyNCT00799942What this trial is testingOpen-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired NystagmusWho this might be right forNystagmus, CongenitalNystagmus, AcquiredMultiple Sclerosis Merz Pharmaceuticals GmbH 48
Not applicableStudy completedNCT00076271What this trial is testingEvaluation and Treatment of Pediatric, Developmental, and Genetic Eye DiseasesWho this might be right forEye Diseases National Eye Institute (NEI) 350